Advertisement

Viral Infection and Multiple Sclerosis

  • Elizabeth L. Williams
  • Steven Jacobson
Chapter
  • 634 Downloads

Keywords

Multiple Sclerosis Experimental Autoimmune Encephalomyelitis Progressive Multifocal Leukoencephalopathy Human Herpesvirus Immediate Early 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Ablashi, D. V., Eastman, H. B., Owen, C. B., et al. (2000) Frequent HHV-6 reactivation in multiple sclerosis (MS) and chronic fatigue syndrome (CFS) patients. J. Clin. Virol. 16:179–191.PubMedGoogle Scholar
  2. Ablashi, D. V., Lapps, W., Kaplan, M., et al. (1998) Human herpesvirus-6 (HHV-6) infection in multiple sclerosis: a preliminary report. Mult. Scler. 4:490–496.PubMedGoogle Scholar
  3. Akhyani, N., Berti, R., Brennan, M. B., et al. (2000) Tissue distribution and variant characterization of human herpesvirus (HHV)-6: increased prevalence of HHV-6A in patients with multiple sclerosis. J. Infect. Dis. 182:1321–1325.PubMedGoogle Scholar
  4. Al-Shammari, S., Nelson, R. F., Voevodin, A. (2003) HHV-6 DNAaemia in patients with multiple sclerosis in Kuwait. Acta Neurol. Scand. 107:122–124.PubMedGoogle Scholar
  5. Albright, A. V., Lavi, E., Black, J. B., et al. (1998) The effect of human herpesvirus-6 (HHV-6) on cultured human neural cells: oligodendrocytes and microglia. J. Neurovirol. 4:486–494.PubMedGoogle Scholar
  6. Alvarez-Lafuente, R., De Las Heras, V., Bartolome, M., et al. (2004a) Beta-interferon treatment reduces human herpesvirus-6 viral load in multiple sclerosis relapses but not in remission. Eur. Neurol. 52:87–91.PubMedGoogle Scholar
  7. Alvarez-Lafuente, R., De las Heras, V., Bartolome, M., et al. (2004b) Relapsing-remitting multiple sclerosis and human herpesvirus 6 active infection. Arch. Neurol. 61:1523–1527.PubMedGoogle Scholar
  8. Alvarez-Lafuente, R., Martin-Estefania, C., de las Heras, V., et al. (2002a) Prevalence of herpesvirus DNA in MS patients and healthy blood donors. Acta Neurol. Scand. 105:95–99.PubMedGoogle Scholar
  9. Alvarez-Lafuente, R., Martin-Estefania, C., de Las Heras, V., et al. (2002b) Active human herpesvirus 6 infection in patients with multiple sclerosis. Arch. Neurol. 59:929–933.PubMedGoogle Scholar
  10. Ascherio, A., Munger, K. L., Lennette, E. T., et al. (2001) Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study. J.A.M.A. 286:3083–3088.PubMedGoogle Scholar
  11. Babbe, H., Roers, A., Waisman, A., et al. (2000) Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J. Exp. Med. 192:393–404.PubMedGoogle Scholar
  12. Barry, M., Bleackley, R. C. (2002) Cytotoxic T lymphocytes: all roads lead to death. Nat. Rev. Immunol. 2:401–409.PubMedGoogle Scholar
  13. Barry, M., Heibein, J. A., Pinkoski, M. J., et al. (2000) Granzyme B short-circuits the need for caspase 8 activity during granule-mediated cytotoxic T-lymphocyte killing by directly cleaving Bid. Mol. Cell. Biol. 20:3781–3794.PubMedGoogle Scholar
  14. Bech, E., Lycke, J., Gadeberg, P., et al. (2002) A randomized, double-blind, placebo-controlled MRI study of anti-herpes virus therapy in MS. Neurology 58:31–36.PubMedGoogle Scholar
  15. Berti, R., Brennan, M. B., Soldan, S. S., et al. (2002) Increased detection of serum HHV-6 DNA sequences during multiple sclerosis (MS) exacerbations and correlation with parameters of MS disease progression. J. Neurovirol. 8:250–256.PubMedGoogle Scholar
  16. Berti, R., Soldan, S. S., Akhyani, N., et al. (2000) Extended observations on the association of HHV-6 and multiple sclerosis. J. Neurovirol. 6(Suppl 2):S85–S87.PubMedGoogle Scholar
  17. Bethge, W., Beck, R., Jahn, G., et al. (1999) Successful treatment of human herpesvirus-6 encephalitis after bone marrow transplantation. Bone Marrow Transplant 24:1245–1248.PubMedGoogle Scholar
  18. Blumberg, B. M., Mock, D. J., Powers, J. M., et al. (2000) The HHV6 paradox: ubiquitous commensal or insidious pathogen? A two-step in situ PCR approach. J. Clin. Virol. 16:159–178.PubMedGoogle Scholar
  19. Booss, J., Esiri, M. M., Tourtellotte, W. W., Mason, D. Y. (1983) Immunohistological analysis of T lymphocyte subsets in the central nervous system in chronic progressive multiple sclerosis. J. Neurol. Sci. 62:219–232.PubMedGoogle Scholar
  20. Bray, P. F., Luka, J., Bray, P. F., et al. (1992) Antibodies against Epstein-Barr nuclear antigen (EBNA) in multiple sclerosis CSF, and two pentapeptide sequence identities between EBNA and myelin basic protein. Neurology 42:1798–1804.PubMedGoogle Scholar
  21. Brudek, T., Christensen, T., Hansen, H. J., et al. (2004) Simultaneous presence of endogenous retrovirus and herpes virus antigens has profound effect on cell-mediated immune responses: implications for multiple sclerosis. AIDS Res. Hum. Retroviruses 20:415–423.PubMedGoogle Scholar
  22. Campadelli-Fiume, G., Mirandola, P., Menotti, L. (1999) Human herpesvirus 6: an emerging pathogen. Emerg. Infect. Dis. 5:353–366.PubMedGoogle Scholar
  23. Carbone, K. M., Luftig, D. B., Buckley, M. R. (2005) Microbial triggers of chronic human illness. In: American Academy of Microbiology Critical Issues Colloquia.Google Scholar
  24. Caselli, E., Boni, M., Bracci, A., et al. (2002) Detection of antibodies directed against human herpesvirus 6 U94/REP in sera of patients affected by multiple sclerosis. J. Clin. Microbiol. 40:4131–4137.PubMedGoogle Scholar
  25. Caserta, M. T., Hall, C. B., Schnabel, K., et al. (1994) Neuroinvasion and persistence of human herpesvirus 6 in children. J. Infect. Dis. 170:1586–1589.PubMedGoogle Scholar
  26. Caserta, M. T., Mock, D. J., Dewhurst, S. (2001) Human herpesvirus 6. Clin. Infect. Dis. 33:829–833.PubMedGoogle Scholar
  27. Cermelli, C., Berti, R., Soldan, S. S., et al. (2003) High frequency of human herpesvirus 6 DNA in multiple sclerosis plaques isolated by laser microdissection. J. Infect. Dis. 187:1377–1387.PubMedGoogle Scholar
  28. Cermelli, C., Jacobson, S. (2000) Viruses and multiple sclerosis. Viral Immunol. 13:255–267.PubMedGoogle Scholar
  29. Challoner, P. B., Smith, K. T., Parker, J. D., et al. (1995) Plaque-associated expression of human herpesvirus 6 in multiple sclerosis. Proc. Natl. Acad. Sci. U S A 92:7440–7444.PubMedGoogle Scholar
  30. Chapenko, S., Millers, A., Nora, Z., et al. (2003) Correlation between HHV-6 reactivation and multiple sclerosis disease activity. J. Med. Virol. 69:111–117.PubMedGoogle Scholar
  31. Christensen, T. (2005) Association of human endogenous retroviruses with multiple sclerosis and possible interactions with herpes viruses. Rev. Med. Virol. 15:179–211.PubMedGoogle Scholar
  32. Clark, D. (2004) Human herpesvirus type 6 and multiple sclerosis. Herpes 11(Suppl 2):112A–119A.PubMedGoogle Scholar
  33. Coates, A. R., Bell, J. (1998) HHV-6 and multiple sclerosis. Nat. Med. 4:537–538.PubMedGoogle Scholar
  34. Crawford, M. P., Yan, S. X., Ortega, S. B., et al. (2004) High prevalence of autoreactive, neuroantigen-specific CD8+ T cells in multiple sclerosis revealed by novel flow cytometric assay. Blood 103:4222–4231.PubMedGoogle Scholar
  35. De Bolle, L., Naesens, L., De Clercq, E. (2005) Update on human herpesvirus 6 biology, clinical features, and therapy. Clin. Microbiol. Rev. 18:217–245.PubMedGoogle Scholar
  36. Denes, E., Magy, L., Pradeau, K., et al. (2004) Successful treatment of human herpesvirus 6 encephalomyelitis in immunocompetent patient. Emerg. Infect. Dis. 10:729–731.PubMedGoogle Scholar
  37. Derfuss, T., Hohlfeld, R., Meinl, E. (2005) Intrathecal antibody (IgG) production against human herpesvirus type 6 occurs in about 20% of multiple sclerosis patients and might be linked to a polyspecific B-cell response. J. Neurol. 252:968–971.PubMedGoogle Scholar
  38. Dewhurst, S., McIntyre, K., Schnabel, K., Hall, C. B. (1993) Human herpesvirus 6 (HHV-6) variant B accounts for the majority of symptomatic primary HHV-6 infections in a population of U.S. infants. J. Clin. Microbiol. 31:416–418.PubMedGoogle Scholar
  39. Dolei, A., Serra, C., Mameli, G., et al. (2002) Multiple sclerosis-associated retrovirus (MSRV) in Sardinian MS patients. Neurology 58:471–473.PubMedGoogle Scholar
  40. Dyment, D. A., Ebers, G. C., Sadovnick, A. D. (2004) Genetics of multiple sclerosis. Lancet Neurol 3:104–110.PubMedGoogle Scholar
  41. Ebers, G. C., Sadovnick, A. D., Risch, N. J. (1995) A genetic basis for familial aggregation in multiple sclerosis: Canadian Collaborative Study Group. Nature 377:150–151.PubMedGoogle Scholar
  42. Enbom, M., Wang, F. Z., Fredrikson, S., et al. (1999) Similar humoral and cellular immunological reactivities to human herpesvirus 6 in patients with multiple sclerosis and controls. Clin. Diagn. Lab. Immunol. 6:545–549.PubMedGoogle Scholar
  43. Ermann, J., Fathman, C. G. (2001) Autoimmune diseases: genes, bugs and failed regulation. Nat. Immunol. 2:759–761.PubMedGoogle Scholar
  44. Ffrench-Constant, C. (1994) Pathogenesis of multiple sclerosis. Lancet 343:271–275.PubMedGoogle Scholar
  45. Fillet, A. M., Lozeron, P., Agut, H., et al. (1998) HHV-6 and multiple sclerosis. Nat. Med. 4:537, author reply 538.PubMedGoogle Scholar
  46. Friedman, J. E., Lyons, M. J., Cu, G., et al. (1999) The association of the human herpesvirus-6 and MS. Mult. Scler. 5:355–362.PubMedGoogle Scholar
  47. Friedman, J. E., Zabriskie, J. B., Plank, C., et al. (2005) A randomized clinical trial of valacyclovir in multiple sclerosis. Mult. Scler. 11:286–295.PubMedGoogle Scholar
  48. Fujinami, R. S., von Herrath, M. G., Christen, U., Whitton, J. L. (2006) Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease. Clin. Microbiol. Rev. 19:80–94.PubMedGoogle Scholar
  49. Gilden, D. H. (2005) Infectious causes of multiple sclerosis. Lancet Neurol 4:195–202.PubMedGoogle Scholar
  50. Gilden, D. H., Devlin, M. E., Burgoon, M. P., Owens, G. P. (1996).The search for virus in multiple sclerosis brain. Mult. Scler. 2:179–183.PubMedGoogle Scholar
  51. Goldberg, S. H., Albright, A. V., Lisak, R. P., Gonzalez-Scarano, F. (1999) Polymerase chain reaction analysis of human herpesvirus-6 sequences in the sera and cerebrospinal fluid of patients with multiple sclerosis. J. Neurovirol. 5:134–139.PubMedGoogle Scholar
  52. Goodman, A. D., Mock, D. J., Powers, J. M., et al. (2003) Human herpesvirus 6 genome and antigen in acute multiple sclerosis lesions. J. Infect. Dis. 187:1365–1376.PubMedGoogle Scholar
  53. Goverman, J., Woods, A., Larson, L., et al. (1993) Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity. Cell 72:551–560.PubMedGoogle Scholar
  54. Green, D. R., Droin, N., Pinkoski, M. (2003) Activation-induced cell death in T cells. Immunol. Rev. 193:70–81.PubMedGoogle Scholar
  55. Guggenmos, J., Schubart, A. S., Ogg, S., et al. (2004) Antibody cross-reactivity between myelin oligodendrocyte glycoprotein and the milk protein butyrophilin in multiple sclerosis. J. Immunol. 172:661–668.PubMedGoogle Scholar
  56. Haahr, S., Sommerlund, M., Moller-Larsen, A., et al. (1991) Just another dubious virus in cells from a patient with multiple sclerosis? Lancet 337:863–864.PubMedGoogle Scholar
  57. Haines, J. L., Terwedow, H. A., Burgess, K., et al. (1998) Linkage of the MHC to familial multiple sclerosis suggests genetic heterogeneity: the Multiple Sclerosis Genetics Group. Hum Mol Genet 7:1229–1234.PubMedGoogle Scholar
  58. Hall, C. B., Caserta, M. T., Schnabel, K. C., et al. (1998) Persistence of human herpesvirus 6 according to site and variant: possible greater neurotropism of variant A. Clin. Infect. Dis. 26:132–137.PubMedGoogle Scholar
  59. Hall, C. B., Long, C. E., Schnabel, K. C, et al. (1994) Human herpesvirus-6 infection in children: a prospective study of complications and reactivation. N. Engl. J. Med. 331:432–438.PubMedGoogle Scholar
  60. He, J., McCarthy, M., Zhou, Y., et al. (1996) Infection of primary human fetal astrocytes by human herpesvirus 6. J. Virol. 70:1296–1300.PubMedGoogle Scholar
  61. Hemmer, B., Archelos, J. J., Hartung, H. P. (2002) New concepts in the immunopathogenesis of multiple sclerosis. Nat. Rev. Neurosci. 3:291–301.PubMedGoogle Scholar
  62. Hilton, D. A., Love, S., Fletcher, A., Pringle, J. H. (1994) Absence of Epstein-Barr virus RNA in multiple sclerosis as assessed by in situ hybridisation. J. Neurol. Neurosurg. Psychiatry 57:975–976.PubMedGoogle Scholar
  63. Hong, J., Tejada-Simon, M. V., Rivera, V. M., et al. (2002) Anti-viral properties of interferon beta treatment in patients with multiple sclerosis. Mult. Scler. 8:237–242.PubMedGoogle Scholar
  64. Huseby, E. S., Liggitt, D., Brabb, T., et al. (2001) A pathogenic role for myelin-specific CD8(+) T cells in a model for multiple sclerosis. J. Exp. Med. 194:669–676.PubMedGoogle Scholar
  65. IFNB (1993) Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial; the IFNB Multiple Sclerosis Study Group. Neurology 43:655–661.Google Scholar
  66. Johnson, R. T. (1994) The virology of demyelinating diseases. Ann. Neurol. 36(Suppl):S54–S60.PubMedGoogle Scholar
  67. Johnston, R. E., Geretti, A. M., Prentice, H. G., et al. (1999) HHV-6-related secondary graft failure following allogeneic bone marrow transplantation. Br. J. Haematol. 105:1041–1043.PubMedGoogle Scholar
  68. Kimberlin, D. W. (1998) Human herpesviruses 6 and 7: identification of newly recognized viral pathogens and their association with human disease. Pediatr. Infect. Dis. J. 17:59–67; quiz 68.PubMedGoogle Scholar
  69. Knox, K. K., Brewer, J. H., Henry, J. M., et al. (2000) Human herpesvirus 6 and multiple sclerosis: systemic active infections in patients with early disease. Clin. Infect. Dis. 31:894–903.PubMedGoogle Scholar
  70. Kurtzke, J. F. (2000) Epidemiology of multiple sclerosis: does this really point toward an etiology? Lectio doctoralis. Neurol. Sci. 21:383–403.PubMedGoogle Scholar
  71. Lawrence, G. L., Chee, M., Craxton, M. A., et al. (1990) Human herpesvirus 6 is closely related to human cytomegalovirus. J. Virol. 64:287–299.PubMedGoogle Scholar
  72. Levin, L. I., Munger, K. L., Rubertone, M. V., et al. (2005) Temporal relationship between elevation of Epstein-Barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis. J.A.M.A. 293:2496–2500.PubMedGoogle Scholar
  73. Liedtke, W., Malessa, R., Faustmann, P. M., Eis-Hubinger, A. M. (1995) Human herpesvirus 6 polymerase chain reaction findings in human immunodeficiency virus associated neurological disease and multiple sclerosis. J. Neurovirol. 1:253–258.PubMedGoogle Scholar
  74. Lindberg, C., Andersen, O., Vahlne, A., et al. (1991) Epidemiological investigation of the association between infectious mononucleosis and multiple sclerosis. Neuroepidemiology 10:62–65.PubMedGoogle Scholar
  75. Lusso, P., Markham, P. D., Tschachler, E., et al. (1988) In vitro cellular tropism of human B-lymphotropic virus (human herpesvirus-6). J. Exp. Med. 167:1659–1670.PubMedGoogle Scholar
  76. Marie, P. (1884) Sclerose en plaques et maladies infectieuses. Prog. Med. Paris 12:287–289.Google Scholar
  77. Martin, C., Enbom, M., Soderstrom, M., et al. (1997) Absence of seven human herpesviruses, including HHV-6, by polymerase chain reaction in CSF and blood from patients with multiple sclerosis and optic neuritis. Acta Neurol. Scand. 95:280–283.PubMedGoogle Scholar
  78. McCullers, J. A., Lakeman, F. D., Whitley, R. J. (1995) Human herpesvirus 6 is associated with focal encephalitis. Clin. Infect. Dis. 21:571–576.PubMedGoogle Scholar
  79. McFarland, H. F., Reingold, S. C. (2005) The future of multiple sclerosis therapies: redesigning multiple sclerosis clinical trials in a new therapeutic era. Mult. Scler. 11:669–676.PubMedGoogle Scholar
  80. Medana, I. M., Gallimore, A., Oxenius, A., et al. (2000) MHC class I-restricted killing of neurons by virus-specific CD8+ T lymphocytes is effected through the Fas/FasL, but not the perforin pathway. Eur. J. Immunol. 30:3623–3633.PubMedGoogle Scholar
  81. Mirandola, P., Menegazzi, P., Merighi, S., et al. (1998) Temporal mapping of transcripts in herpesvirus 6 variants. J. Virol. 72:3837–844.PubMedGoogle Scholar
  82. Mirandola, P., Stefan, A., Brambilla, E., et al. (1999) Absence of human herpesvirus 6 and 7 from spinal fluid and serum of multiple sclerosis patients. Neurology 53:1367–1368.PubMedGoogle Scholar
  83. Mock, D. J., Powers, J. M., Goodman, A. D., et al. (1999) Association of human herpesvirus 6 with the demyelinative lesions of progressive multifocal leukoencephalopathy. J. Neurovirol. 5:363–373.PubMedGoogle Scholar
  84. Monteiro, J., Hingorani, R, Pergolizzi, R., et al. (1995) Clonal dominance of CD8+ T-cell in multiple sclerosis. Ann. N.Y. Acad. Sci. 756:310–312.PubMedGoogle Scholar
  85. Mookerjee, B. P., Vogelsang, G. (1997) Human herpes virus-6 encephalitis after bone marrow transplantation: successful treatment with ganciclovir. Bone Marrow Transplant. 20:905–906.PubMedGoogle Scholar
  86. Morre, S. A., van Beek, J., De Groot, C. J., et al. (2001) Is Epstein-Barr virus present in the CNS of patients with MS? Neurology 56:692.PubMedGoogle Scholar
  87. Mouzaki, A., Tselios, T., Papathanassopoulos, P., et al. (2004) Immunotherapy for multiple sclerosis: basic insights for new clinical strategies. Curr. Neurovasc. Res. 1:325–340.PubMedGoogle Scholar
  88. Neumann, H., Medana, I. M., Bauer, J., Lassmann, H. (2002) Cytotoxic T lymphocytes in autoimmune and degenerative CNS diseases. Trends Neurosci. 25:313–319.PubMedGoogle Scholar
  89. Nielsen, L., Larsen, A. M., Munk, M., Vestergaard, B. F. (1997) Human herpesvirus-6 immunoglobulin G antibodies in patients with multiple sclerosis. Acta Neurol. Scand. Suppl. 169:76–78.PubMedGoogle Scholar
  90. Okuno, T., Takahashi, K., Balachandra, K., et al. (1989) Seroepidemiology of human herpesvirus 6 infection in normal children and adults. J. Clin. Microbiol. 27:651–653.PubMedGoogle Scholar
  91. Ongradi, J., Rajda, C., Marodi, CL., et al. (1999) A pilot study on the antibodies to HHV-6 variants and HHV-7 in CSF of MS patients. J. Neurovirol. 5:529–532.PubMedGoogle Scholar
  92. Opsahl, M. L., Kennedy, P. G. (2005) Early and late HHV-6 gene transcripts in multiple sclerosis lesions and normal appearing white matter. Brain 128:516–527.PubMedGoogle Scholar
  93. Rapaport, D., Engelhard, D., Tagger, G., et al. (2002) Antiviral prophylaxis may prevent human herpesvirus-6 reactivation in bone marrow transplant recipients. Transpl. Infect. Dis. 4:10–16.PubMedGoogle Scholar
  94. Rieux, C., Gautheret-Dejean, A., Challine-Lehmann, D., et al. (1998) Human herpesvirus-6 meningoencephalitis in a recipient of an unrelated allogeneic bone marrow transplantation. Transplantation 65:1408–1411.PubMedGoogle Scholar
  95. Rossi, C., Delforge, M. L., Jacobs, F., et al. (2001) Fatal primary infection due to human herpesvirus 6 variant A in a renal transplant recipient. Transplantation 71:288–292.PubMedGoogle Scholar
  96. Rotola, A., Merlotti, I., Caniatti, L., et al. (2004) Human herpesvirus 6 infects the central nervous system of multiple sclerosis patients in the early stages of the disease. Mult. Scler. 10:348–354.PubMedGoogle Scholar
  97. Russell, J. H., Ley, T. J. (2002) Lymphocyte-mediated cytotoxicity. Annu. Rev. Immunol. 20:323–370.PubMedGoogle Scholar
  98. Saito, Y., Sharer, L. R., Dewhurst, S., et al. (1995) Cellular localization of human herpesvirus-6 in the brains of children with AIDS encephalopathy. J. Neurovirol. 1:30–39.PubMedGoogle Scholar
  99. Salahuddin, S. Z., Ablashi, D. V., Markham, P. D., et al. (1986) Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science 234:596–601.PubMedGoogle Scholar
  100. Sanders, V. J., Felisan, S., Waddell, A., Tourtellotte, W. W. (1996) Detection of herpesviridae in postmortem multiple sclerosis brain tissue and controls by polymerase chain reaction. J. Neurovirol. 2:249–258.PubMedGoogle Scholar
  101. Shresta, S., Pham, C. T., Thomas, D. A., et al. (1998) How do cytotoxic lymphocytes kill their targets? Curr. Opin. Immunol. 10:581–587.PubMedGoogle Scholar
  102. Sibley, W. A., Bamford, C. R., Clark, K. (1985) Clinical viral infections and multiple sclerosis. Lancet 1:1313–1315.PubMedGoogle Scholar
  103. Singh, N., Bonham, A., Fukui, M. (2000) Immunosuppressive-associated leukoencephalopathy in organ transplant recipients. Transplantation 69:467–472.PubMedGoogle Scholar
  104. Sola, P., Merelli, E., Marasca, R., et al. (1993) Human herpesvirus 6 and multiple sclerosis: survey of anti-HHV-6 antibodies by immunofluorescence analysis and of viral sequences by polymerase chain reaction. J. Neurol. Neurosurg. Psychiatry 56:917–919.PubMedGoogle Scholar
  105. Soldan, S. S., Berti, R., Salem, N., et al. (1997) Association of human herpes virus 6 (HHV-6) with multiple sclerosis: increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA. Nat. Med. 3:1394–1397.PubMedGoogle Scholar
  106. Soldan, S. S., Leist, T. P., Juhng, K. N., et al. (2000) Increased lymphoproliferative response to human herpesvirus type 6A variant in multiple sclerosis patients. Ann. Neurol. 47:306–313.PubMedGoogle Scholar
  107. Sospedra, M., Martin, R. (2005) Immunology of multiple sclerosis. Annu. Rev. Immunol. 23:683–747.PubMedGoogle Scholar
  108. Steinman, L. (2001a) Multiple sclerosis: a two-stage disease. Nat. Immunol. 2:762–764.PubMedGoogle Scholar
  109. Steinman, L. (2001b). Myelin-specific CD8 T cells in the pathogenesis of experimental allergic encephalitis and multiple sclerosis. J. Exp. Med. 194:F27–F30.PubMedGoogle Scholar
  110. Steinman, L., Zamvil, S. (2003) Transcriptional analysis of targets in multiple sclerosis. Nat. Rev. Immunol. 3:483–492.PubMedGoogle Scholar
  111. Sundstrom, P., Juto, P., Wadell, G., et al. (2004) An altered immune response to Epstein-Barr virus in multiple sclerosis: a prospective study. Neurology 62:2277–2282.PubMedGoogle Scholar
  112. Swanborg, R. H., Whittum-Hudson, J. A., Hudson, A. P. (2003) Infectious agents and multiple sclerosis—are Chlamydia pneumoniae and human herpes virus 6 involved? J. Neuroimmunol. 136:1–8.PubMedGoogle Scholar
  113. Taus, C., Pucci, E., Cartechini, E., et al. (2000) Absence of HHV-6 and HHV-7 in cerebrospinal fluid in relapsing-remitting multiple sclerosis. Acta Neurol. Scand. 101:224–228.PubMedGoogle Scholar
  114. Tejada-Simon, M. V., Zang, Y. C., Hong, J., et al. (2002) Detection of viral DNA and immune responses to the human herpesvirus 6 101-kilodalton virion protein in patients with multiple sclerosis and in controls. J. Virol. 76:6147–6154.PubMedGoogle Scholar
  115. Tiacci, E., Luppi, M., Barozzi, P., et al. (2000) Fatal herpesvirus-6 encephalitis in a recipient of a T-cell-depleted peripheral blood stem cell transplant from a 3-loci mismatched related donor. Haematologica 85:94–97.PubMedGoogle Scholar
  116. Tokimasa, S., Hara, J., Osugi, Y., et al. (2002) Ganciclovir is effective for prophylaxis and treatment of human herpesvirus-6 in allogeneic stem cell transplantation. Bone Marrow Transplant 29:595–598.PubMedGoogle Scholar
  117. Tomsone, V., Logina, I., Millers, A., et al. (2001) Association of human herpesvirus 6 and human herpesvirus 7 with demyelinating diseases of the nervous system. J. Neurovirol. 7:564–569.PubMedGoogle Scholar
  118. Trapani, J. A., Davis, J., Sutton, V. R., Smyth, M. J. (2000) Proapoptotic functions of cytotoxic lymphocyte granule constituents in vitro and in vivo. Curr. Opin. Immunol. 12:323–329.PubMedGoogle Scholar
  119. Vass, K., Lassmann, H. (1990) Intrathecal application of interferon gamma: progressive appearance of MHC antigens within the rat nervous system. Am. J. Pathol. 137:789–800.PubMedGoogle Scholar
  120. Villoslada, P., Juste, C., Tintore, M., et al. (2003) The immune response against herpesvirus is more prominent in the early stages of MS. Neurology 60:1944–1948.PubMedGoogle Scholar
  121. Virtanen, J. O., Zabriskie, J. B., Siren, V., et al. (2005) Co-localization of human herpes virus 6 and tissue plasminogen activator in multiple sclerosis brain tissue. Med. Sci. Monit. 11:BR84-BR87.PubMedGoogle Scholar
  122. Wainwright, M. S., Martin, P. L., Morse, R. P., et al. (2001) Human herpesvirus 6 limbic encephalitis after stem cell transplantation. Ann. Neurol. 50:612–619.PubMedGoogle Scholar
  123. Wang, F. Z., Linde, A., Hagglund, H., et al. (1999) Human herpesvirus 6 DNA in cerebrospinal fluid specimens from allogeneic bone marrow transplant patients: does it have clinical significance? Clin. Infect. Dis. 28:562–568.PubMedGoogle Scholar
  124. Wilborn, F., Schmidt, C. A., Brinkmann, V., et al. (1994) A potential role for human herpesvirus type 6 in nervous system disease. J. Neuroimmunol. 49:213–214.PubMedGoogle Scholar
  125. Woodland, D. L., Dutton, R. W. (2003) Heterogeneity of CD4(+) and CD8(+) T cells. Curr. Opin. Immunol. 15:336–342.PubMedGoogle Scholar
  126. Wucherpfennig, K. W., Strominger, J. L. (1995) Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 80:695–705.PubMedGoogle Scholar
  127. Xu, Y., Linde, A., Fredrikson, S., et al. (2002) HHV-6 A- or B-specific P41 antigens do not reveal virus variant-specific IgG or IgM responses in human serum. J. Med. Virol. 66:394–399.PubMedGoogle Scholar
  128. Yamanishi, K., Okuno, T., Shiraki, K., et al. (1988) Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet 1:1065–1067.PubMedGoogle Scholar
  129. Yoshida, H., Matsunaga, K., Ueda, T., et al. (2002) Human herpesvirus 6 meningoencephalitis successfully treated with ganciclovir in a patient who underwent allogeneic bone marrow transplantation from an HLA-identical sibling. Int. J. Hematol. 75:421–425.PubMedGoogle Scholar
  130. Yoshikawa, T., Asano, Y. (2000) Central nervous system complications in human herpesvirus-6 infection. Brain Dev. 22:307–314.PubMedGoogle Scholar
  131. Zawada, M., Liwien, I., Pernak, M., et al. (2003) MSRV pol sequence copy number as a potential marker of multiple sclerosis. Pol. J. Pharmacol. 55:869–875.PubMedGoogle Scholar
  132. Zerr, D. M., Gupta, D., Huang, M. L., et al. (2002) Effect of antivirals on human herpesvirus 6 replication in hematopoietic stem cell transplant recipients. Clin. Infect. Dis. 34:309–317.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  • Elizabeth L. Williams
    • 1
  • Steven Jacobson
    • 1
  1. 1.Viral Immunology SectionNINDS/NIHBethesdaUSA

Personalised recommendations